SPARC and type 2 diabetes mellitus: That being said, others have shown that some of the cytokines (i.e., SPARC, IL-6, IL-10, IL-13, IL-15, and IL-18) we quantified in our cohort can be altered in the circulation of patients with T2D, as we reviewed in 2019 [13].